NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

Access full document

Details

Contract Title:NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Published Date:Feb 26, 2026
Notice Type:Award (ContractAwardNotice)
Value Banding:High Value
Delivery Point:United Kingdom

Description:

Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026 Offer reference number: CM/TNS/25/5736 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/25/5736 Nintedanib and Dalbavancin Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months) Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months) Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9...


Back to search results